Navigation Links
New Canadian study finds drug coated heart stents to be safe:
Date:10/3/2007

and the University of Toronto, says, "Physicians implanting the devices need to ensure patients who get a drug-eluting stent also take anti-clotting medication such as aspirin and clopidogrel (antiplatelet therapy) for a minimum of one year after the angioplasty procedure. This therapy reduces the risk of fatal blood clots associated with drug-eluting stents. This prolonged period of clopidogrel usage could explain differences between results in Ontario, compared to those from other countries, such as Sweden. In our study, these medications were made available to all elderly patients in Ontario, at minimal cost, through the Ontario Drug Benefits Program for one year after the angioplasty procedure."

Since their introduction in 2003, more than six million heart patients worldwide have received a drug-eluting stent (DES). The DES market is worth $5 billion a year, costing about $2300 for a DES versus $700 for a bare metal stent (BMS). The rate of DES use in countries like the United States was as high as 90% but dropped to about 70% in the past year, after recent controversy over safety. Recent studies from Europe and Sweden suggest DES may increase mortality and heart attack after a coronary angioplasty. The rate of DES usage in Ontario was on average 38% of all stents during the study period. In 2003, the Ontario government approved the introduction of DES provincially, conditional upon an independent evaluation of their effectiveness and cost-effectiveness. Approximately 20,000 angioplasties are performed each year in the province of Ontario.

The study "Effectiveness and safety of drug-eluting stents in Ontario" is in the October 4th issue of the New England Journal of Medicine. The study was funded by operating grants from the Ontario Ministry of Health and Long-term Care and a Canadian Institutes of Health Research Team Grant in Cardiovascular Outcomes Research.

Author affiliations: ICES (J.V.T., M.C., D.T.K., P.C.A., Y.H.) and Sunnybrook Healt
'/>"/>

SOURCE Institute for Clinical Evaluative Sciences
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Frozen Canadian baby stages miraculous recovery
2. Canadian Street Prostitutes Requests Protection
3. Rural Canadians travel far for specialists: study
4. Canadian Youth at risk of heart disease
5. Canadians flocking to India for quick and efficient medical treatment
6. CPHA Offers HIV Information Packages To Canadian Football League Teams
7. Insomnia Hits Many Canadians: Survey
8. Canadians Oblivious About COPD, A Debilitating Lung Disease
9. Disparity In Survival Rates In US and Canadian heart Patients
10. Canadian health on the decline, due to a drinking problem
11. Lack of facilities in emergency rooms, warn Canadian nurses!

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , DEL MAR, Calif., Nov. 30 /PRNewswire...ration (Pink Sheets: ADHC) is pleased to announce ...dependent director to the Company,s Board of Direc...s over a 40 year period starting at the Chemical B...artner of Harris, Bretall & McEldowney, San Fr...
(Date:11/30/2009)..., , PHILADELPH...l/ -- , - Exclusive Updates From Elsevier...re Reform and ARRA Momentum , Elsevier, a...on as well,as web-based and electronic health reco...ew online resource center for American Recovery an...
(Date:11/30/2009)... The U.S. Centers for Disease Control and Preventi...he United States are infected with HIV/AIDS. New r... that many of those infected are minorities and do...d for a national strategy to facilitate education ...populations. , The research, which analyzed 90,0...
(Date:11/30/2009)... The University of Navarra Hospital has launched a...efficacy of an immunotherapy treatment. This appro...nes produced from healthy and tumour cells from th...ioblastomas, one of the most aggressive and freque...red to participating patients combined with the st...
(Date:11/30/2009)...lder alcoholics tend to drink heavily more often t...NDAY, Nov. 30 (HealthDay News) -- Older people who...eir younger counterparts, a new report finds, poss... same effect. , According to a study released ...der than 60 consume more than 40 drinks a week, on...
Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 3Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 4Health News:Research highlights need for national HIV strategy 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:Binge Drinking Not Just a Rite of the Young 2
...P(R),s charitable Sight for Students(R) program an...ception in 1997. The program has funded almost $10...me, uninsured and underinsured children. , , (P...ce, the nation,s largest partnership network worki...
... Treatments , , OTTAWA, March 9 /PRNewswire-First... isotopes and radiopharmaceuticals, today announce...for TheraSphere(R), Yttrium-90 Microsphere (Y-90),...er, faster, and more efficient administration of T...
...d expect to need reading glasses or bifocals durin...ed presbyopia. LASIK, a proven technique for freed...r presbyopia. , , But today, according to result...mpletely eliminated the need for all glasses for 9...
...mex: HH ) today announced that it will release f...before market on Friday, March 13, 2009. The Comp...3, 2009 at 11:00am Eastern Time. , , Conferen...n the Company,s web site located at www.hooperhol...
...f Cosmetic Scientists Meeting , , PROVO, Utah, Ma...nternal free radical generator, age-related NOX (a...ses, Inc. (NYSE: NUS ) links the enzyme to age-r... of Cosmetic Scientists (ASCS), March 2-4, in Yoko...
...Take a Second Look at Patent in a Reexamination Pr... Community , , NEW YORK, March 9 Article One Par...he validity of Merck & Co.,s SINGULAIR U.S. dr...an independent expert join Article One,s opinion t...
Other Medicine News:Health News:VSP's Sight for Students Program Helps 500,000th Child 2Health News:VSP's Sight for Students Program Helps 500,000th Child 3Health News:MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians 2Health News:MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians 3Health News:Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information 2Health News:Study Links Internal Source of Aging and Skin Damage 2Health News:Study Links Internal Source of Aging and Skin Damage 3Health News:Article One Partners Uncovers New Prior Art Impacting the Validity of Merck's SINGULAIR Patent 2Health News:Article One Partners Uncovers New Prior Art Impacting the Validity of Merck's SINGULAIR Patent 3Health News:Article One Partners Uncovers New Prior Art Impacting the Validity of Merck's SINGULAIR Patent 4
(Date:11/30/2009)...Newswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MED...ical documentation services, today announced that ...ons, Inc. (Nuance) under which MedQuist will now l...ine and processing software for use in SpeechQ of ...recognition application for all medical discipline...
(Date:11/30/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Diabetes Diagnostics - A Global Market ...164347/Diabetes-Diagnostics---A-Global-Market-Pers...driven by a steady increase in the number of peopl...nd developing parts of the world, and increase in ...
(Date:11/30/2009)...-- Dr. Jocelyn Rapelyea, Associate Director of Bre...University Medical Center in Washington, D.C., dem...t-Specific Gamma Imaging (BSGI) can be localized u...as well, as for pre-operative localization today a...f North America (RSNA). ,, BSGI was conducted u...
Breaking Medicine Technology:MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Breast Cancer Numbers Dip Most in Wealthy Urban Areas 50200 1Breast Cancer Numbers Dip Most in Wealthy Urban Areas 50200 2The Psychology of Celebrity Worship 50198 1The Psychology of Celebrity Worship 50198 2The Psychology of Celebrity Worship 50198 3Discus Dental Files Suit to Protect BriteSmile 28R 29 Trademark 50197 1Discus Dental Files Suit to Protect BriteSmile 28R 29 Trademark 50197 2
...June 4 AstraZeneca (NYSE:,AZN) today announced th...n,(sNDA) to the U.S. Food and Drug Administration ...RT(R) (budesonide/formoterol fumarate dihydrate),I...eatment of asthma in,pediatric patients ages 6 to ...the long-term maintenance treatment of asthma in p...
... 4 Semafore Pharmaceuticals Inc.,today reported i...ct,candidate, SF1126, a targeted pan-PI3 kinase (P...mors. SF1126 is the first PI3 kinase inhibitor to ...ltiple myeloma trials., The data from the solid t...ed in a twice-weekly I.V. infusion at exposure lev...
Other Medicine Technology:AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 2AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 3AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 4AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 5AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 6Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors 2Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors 3
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: